Net treatment | Total tested/collected | % deterency (95% CI) | % exophily (95% CI) | % blood-fed (95% CI) | Personal protection (no. Fed) | % immediate mortality (95% CI) | % overall mortality (95% CI) |
---|---|---|---|---|---|---|---|
AKRON | |||||||
Untreated net | 144 | - | 47.92 - | 26.39 - | - | 14.58 [0.16-0.64] | 15.97 [0.12-0.47] |
Unwashed LifeNet | 63 | 56.25 | 71.43 [1.44-5.21] | 15.87 [0.23-1.12] | 73.63 | 34.92 - | 44.44 - |
LifeNet 30 X | 69 | 52.08 [0.53-1.35] | 81.16 [2.38-9.53] | 17.39 [0.28-1.19] | 68.42 | 34.78 [0.48-2.05] | 47.83 [0.57-2.29] |
LifeNet 40 X | 55 | 61.81 [0.78-2.02] | 72.73 [1.48-5.81] | 09.09 [0.09-0.72] | 86.84 | 41.82 [0.63-2.84] | 47.27 [0.54-2.33] |
Olyset 30 X | 37 | 74.31 [1.37-3.71] | 59.46 [0.76-3.37] | 29.73 [0.51-2.59] | 71.05 | 21.62 [0.19-1.30] | 21.62 [0.13-0.86] |
Olyset 40 X | 40 | 72.22 [1.24-3.31] | 65.00 [0.98-4.25] | 20.00 [0.28-1.62] | 78.95 | 32.50 [0.38-2.09] | 35.00 [0.29-1.53] |
Permanet 30 X | 79 | 45.14 [0.40-1.02] | 56.96 [0.83-2.51] | 32.91 [0.75-2.49] | 31.58 | 32.91 [0.45-1.85] | 36.71 [0.37-1.43] |
Permanet 40 X | 103 | 28.47 [0.19-0.51] | 45.63 [0.55-1.31] | 38.83 [1.03-3.05] | -5.26 | 16.50 [0.18-0.77] | 18.45 [0.14-0.58] |
MALANVILLE | |||||||
Untreated net | 911 | - | 31.39 - | 15.48 - | - | 00.99 [0.02-0.06] | 01.65 [0.01-0.03] |
Unwashed LifeNet | 676 | 25.8 | 58.88 [2.54-3.85] | 05.47 [0.21-0.46] | 73.76 | 23.22 - | 44.97 - |
LifeNet 30 X | 563 | 38.2 [1.46-2.17] | 54.88 [2.14-3.30] | 07.99 [0.33-0.67] | 60.09 | 17.23 [0.52-0.91] | 30.37 [0.42-0.68] |
LifeNet 40 X | 679 | 25.47 [0.80-1.21] | 59.20 [2.58-3.90] | 07.95 [0.34-0.65] | 61.70 | 19.15 [0.60-1.02] | 36.23 [0.56-0.86] |
Olyset 30 X | 581 | 36.22 [1.34-1.99] | 48.71 [1.67-2.57] | 10.84 [0.48-0.91] | 55.32 | 13.25 [0.37-0.68] | 29.43 [0.40-0.64] |
Olyset 40 X | 484 | 46.87 [2.08-3.09] | 53.72 [2.02-3.18] | 11.57 [0.51-0.99] | 60.28 | 17.77 [0.53-0.95] | 26.86 [0.35-0.58] |